Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jan 2;68(1):20-8.
doi: 10.1212/01.wnl.0000250355.28474.8e.

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

NINDS NET-PD Investigators  1
Affiliations
Randomized Controlled Trial

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

NINDS NET-PD Investigators. Neurology. .

Abstract

Objective: To determine if future studies of coenzyme Q(10) and GPI-1485 in Parkinson disease (PD) may be warranted.

Methods: We conducted a randomized, double-blind, calibrated futility clinical trial of coenzyme Q10 and GPI-1485 in early untreated PD using placebo data from the DATATOP study to establish the futility threshold.

Results: The primary outcome measure (change in total Unified Parkinson's Disease Rating Scale scores over 1 year) did not meet the prespecified criteria for futility for either agent. Secondary analyses using calibration controls and other more recent placebo data question the appropriateness of the predetermined definition of futility, and suggest that a more restrictive threshold may be needed.

Conclusions: Coenzyme Q(10) and GPI-1485 may warrant further study in Parkinson disease, although the data are inconsistent. Additional factors (cost, availability of other agents, more recent data on placebo outcomes, other ongoing trials) should also be considered in the selection of agents for Phase III studies.

PubMed Disclaimer

Publication types